Cargando…
Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is the second most common Parkinsonian disorder with complex etiology. The underlying molecular mechanism of PSP pathogenesis remains unclear. The present study aims to find the feasibility of using plasma miRNAs as novel biomarkers. Plasma-focused qPCR panels we...
Autores principales: | Ramaswamy, Palaniswamy, Christopher, Rita, Kumar Pal, Pramod, Debnath, Monojit, Yadav, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139891/ https://www.ncbi.nlm.nih.gov/pubmed/35626359 http://dx.doi.org/10.3390/diagnostics12051204 |
Ejemplares similares
-
Genetic and Epigenetic Constructs of Progressive Supranuclear Palsy
por: Debnath, Monojit, et al.
Publicado: (2022) -
Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker
por: Ramaswamy, Palaniswamy, et al.
Publicado: (2020) -
Can Circulating microRNAs Identify Sudden Unexpected Death in Parkinson's Disease ?
por: Ramaswamy, Palaniswamy, et al.
Publicado: (2021) -
The Non-Motor Symptom Profile of Progressive Supranuclear Palsy
por: Chaithra, Sudhakar Pushpa, et al.
Publicado: (2020) -
Sleep Architecture in Progressive Supranuclear Palsy: A Video-Polysomnography Study
por: Boini, Srikanth Yadav, et al.
Publicado: (2022)